Predictive Oncology (Nasdaq: POAI), an AI-driven drug discovery company that has expanded its business to include a digital asset strategy focused on ATH ...

Chao-Yi Wu, PhD, OT, from the Department of Neurology and Edmarie Guzmán-Vélez, PhD, of the Department of Psychiatry at Mass General Brigham, are the lead and senior authors of a paper published in ...

Predictive Oncology (Nasdaq: POAI) , an AI-driven drug discovery company that has expanded its business to include a digital asset strategy focused on ATH, the native utility token of the Aethir ...

A surge in market liquidity is imminent, driven by potential government stimulus checks and the end of the U.S. government ...

I was always going to be a little skeptical of Petit Planet. In my review of Animal Crossing: New Horizons, I mentioned how ...

If you don't mind a slightly underbaked camera, the OnePlus 15 is tremendous, offering among the best displays, performance ...

As the U.S. Food and Drug Administration (FDA) proposed, Clene is concluding analyses of its ALS biomarker data with completion planned shortly ...

Total revenues in the first nine months of the year were $420 million, a 24% increase from the same period last year Product and service revenue ...

The global economy is shifting from software intelligence to embodied AI — where algorithms meet physical production.